| Genetic variation in IL28B and spontaneous clearance of hepatitis C virus DL Thomas, CL Thio, MP Martin, Y Qi, D Ge, C O’hUigin, J Kidd, K Kidd, ... Nature 461 (7265), 798-801, 2009 | 2754 | 2009 |
| HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection SI Khakoo, CL Thio, MP Martin, CR Brooks, X Gao, J Astemborski, ... Science 305 (5685), 872-874, 2004 | 1495 | 2004 |
| MAIT cells are activated during human viral infections B Van Wilgenburg, I Scherwitzl, EC Hutchinson, T Leng, A Kurioka, ... Nature communications 7 (1), 11653, 2016 | 517 | 2016 |
| HIV-1 adaptation to NK-cell-mediated immune pressure G Alter, D Heckerman, A Schneidewind, L Fadda, CM Kadie, JM Carlson, ... Nature 476 (7358), 96-100, 2011 | 465 | 2011 |
| KIR and disease: a model system or system of models? SI Khakoo, M Carrington Immunological reviews 214 (1), 186-201, 2006 | 361 | 2006 |
| Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans SI Khakoo, R Rajalingam, BP Shum, K Weidenbach, L Flodin, DG Muir, ... Immunity 12 (6), 687-698, 2000 | 336 | 2000 |
| Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts P Duggal, CL Thio, GL Wojcik, JJ Goedert, A Mangia, R Latanich, AY Kim, ... Annals of internal medicine 158 (4), 235-245, 2013 | 258 | 2013 |
| Activation of natural killer cells during acute infection with hepatitis C virus B Amadei, S Urbani, A Cazaly, P Fisicaro, A Zerbini, P Ahmed, G Missale, ... Gastroenterology 138 (4), 1536-1545, 2010 | 230 | 2010 |
| Consistent beneficial effects of killer cell immunoglobulin‐like receptor 2DL3 and group 1 human leukocyte antigen‐C following exposure to hepatitis C virus S Knapp, U Warshow, D Hegazy, L Brackenbury, IN Guha, A Fowell, ... Hepatology 51 (4), 1168-1175, 2010 | 210 | 2010 |
| Peptide antagonism as a mechanism for NK cell activation L Fadda, G Borhis, P Ahmed, K Cheent, SV Pageon, A Cazaly, ... Proceedings of the National Academy of Sciences 107 (22), 10160-10165, 2010 | 199 | 2010 |
| Immunotherapy for hepatocellular carcinoma: current and future MP Johnston, SI Khakoo World journal of gastroenterology 25 (24), 2977, 2019 | 185 | 2019 |
| Natural killer cells: integrating diversity with function K Cheent, SI Khakoo Immunology 126 (4), 449-457, 2009 | 182 | 2009 |
| The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation M Luevano, M Daryouzeh, R Alnabhan, S Querol, S Khakoo, A Madrigal, ... Human immunology 73 (3), 248-257, 2012 | 178 | 2012 |
| Ribavirin and interferon alfa‐2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions S Khakoo, P Glue, L Grellier, B Wells, A Bell, C Dash, I Murray‐Lyon, ... British journal of clinical pharmacology 46 (6), 563-570, 1998 | 167 | 1998 |
| KIR/HLA interactions and pathogen immunity KM Jamil, SI Khakoo BioMed Research International 2011 (1), 298348, 2011 | 156 | 2011 |
| Hanging in the balance AP Williams, AR Bateman, SI Khakoo Molecular interventions 5 (4), 226, 2005 | 153 | 2005 |
| Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experience SM Vidal, SI Khakoo, CA Biron Current opinion in virology 1 (6), 497-512, 2011 | 152 | 2011 |
| Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses S Pelletier, C Drouin, N Bédard, SI Khakoo, J Bruneau, NH Shoukry Journal of hepatology 53 (5), 805-816, 2010 | 144 | 2010 |
| Histological assessment of the Sydney classification of endoscopic gastritis. SI Khakoo, AJ Lobo, NA Shepherd, SP Wilkinson Gut 35 (9), 1172-1175, 1994 | 135 | 1994 |
| Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus MA Ansari, V Pedergnana, C LC Ip, A Magri, A Von Delft, D Bonsall, ... Nature genetics 49 (5), 666-673, 2017 | 134 | 2017 |
